Wordt geladen...
Mutant prevention concentration of tigecycline for clinical isolates of Streptococcus pneumoniae and Staphylococcus aureus
BACKGROUND: The mutant prevention concentration (MPC) reflects the antimicrobial susceptibility of the resistant mutant subpopulations present in large bacterial populations. In principle, combining the MPC with pharmacokinetic measurements can guide treatment to restrict the enrichment of resistant...
Bewaard in:
| Gepubliceerd in: | J Antimicrob Chemother |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4291236/ https://ncbi.nlm.nih.gov/pubmed/25324419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dku389 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|